Jonathan Vo, FNP
Family · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jonathan Vo’s office at (408) 694-2444 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$2,045 in 2024
Medicaid paid $2,045 for 220 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 112 | $2,045 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 108 | $0 |
| 2024 | 220 | 2 | 23 | $2,045 |
| 2023 | 44 | 2 | 16 | $159 |
| 2022 | 38 | 2 | 13 | $0 |
| 2021 | 913 | 7 | 40 | $176,082 |
| 2020 | 345 | 4 | 50 | $61,082 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 12 | $159 |
| Hemoglobin A1C level | 32 | $0 |
2022
| Albumin; urine (eg, microalbumin), quantitative | 12 | $0 |
| Hemoglobin A1C level | 26 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 375 | $176,082 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 17 | $0 |
| Albumin; urine (eg, microalbumin), quantitative | 13 | $0 |
| Creatinine; other source | 12 | $0 |
| Hemoglobin A1C level | 41 | $0 |
| Short return visit | 377 | $0 |
| Return visit (30+ min) | 78 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 191 | $61,082 |
| Hemoglobin A1C level | 12 | $0 |
| Short return visit | 55 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 87 | $0 |
Drugs they prescribed that Part D paid
$886,711
Pharmacies billed $886,711 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,296) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,243 generic and 894 brand-name prescriptions · $886,711 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 210 | $272,448 | $1,297 |
| Trulicity | 166 | $246,103 | $1,483 |
| Tradjenta | 73 | $96,542 | $1,322 |
| Ozempic | 77 | $77,795 | $1,010 |
| Januvia | 46 | $55,343 | $1,203 |
See all 34 drugs
| Jardiance | 210 | $272,448 | $1,297 |
| Trulicity | 166 | $246,103 | $1,483 |
| Tradjenta | 73 | $96,542 | $1,322 |
| Ozempic | 77 | $77,795 | $1,010 |
| Januvia | 46 | $55,343 | $1,203 |
| Tresiba Flextouch U-200 | 20 | $23,680 | $1,184 |
| Semglee (Yfgn) | 56 | $20,734 | $370 |
| Mounjaro | 17 | $18,689 | $1,099 |
| Basaglar Kwikpen U-100 | 52 | $14,742 | $283 |
| Insulin Aspart Flexpen | 44 | $8,079 | $184 |
| Semglee (Yfgn) | 12 | $7,368 | $614 |
| Ultra-Fine Short Pen Needle | 50 | $4,658 | $93 |
| Ultra-Fine Mini Pen Needle | 51 | $3,466 | $68 |
| Novolin N Flexpen | 17 | $1,928 | $113 |
| Glipizide | 177 | $1,830 | $10 |
| Novolin 70-30 | 13 | $1,746 | $134 |
| Ultra-Fine Nano Pen Needle | 21 | $1,702 | $81 |
| Metformin | 221 | $1,633 | $7 |
| Lantus Solostar | 21 | $1,282 | $61 |
| Lantus | 15 | $1,109 | $74 |
| Atorvastatin | 193 | $1,090 | $6 |
| Fosinopril | 57 | $955 | $17 |
| Metformin Hcl Er | 51 | $563 | $11 |
| Losartan | 74 | $521 | $7 |
| Insulin | 11 | $507 | $46 |
| Amlodipine Besylate | 139 | $449 | $3 |
| Glipizide Er | 20 | $365 | $18 |
| Simvastatin | 44 | $241 | $5 |
| Atenolol | 34 | $165 | $5 |
| Gabapentin | 15 | $156 | $10 |
| Benazepril | 13 | $154 | $12 |
| Metoprolol | 23 | $121 | $5 |
| Lisinopril | 32 | $116 | $4 |
| Hydrochlorothiazide | 40 | $87 | $2 |
Year by year
| 2024 | 2,296 | 179 | 0% (0) | 39% | $886,711 |
| 2023 | 1,246 | 160 | 0% (0) | 40% | $591,661 |
| 2022 | 1,501 | 147 | 0% (0) | 33% | $600,966 |
| 2021 | 2,190 | 177 | 0% (0) | 38% | $817,560 |
| 2020 | 2,041 | 172 | 0% (0) | 37% | $609,794 |
| 2019 | 1,299 | 108 | 0% (0) | 41% | $444,769 |
| 2018 | 1,070 | 161 | 0% (0) | 33% | $269,581 |
| 2017 | 1,934 | 454 | None | 30% | $207,230 |
| 2016 | 2,870 | 517 | None | 30% | $212,906 |
| 2015 | 973 | 246 | 5% (51) | 24% | $56,879 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Trulicity | 131 | $215,333 | $1,644 |
| Jardiance | 78 | $111,231 | $1,426 |
| Tradjenta | 46 | $70,449 | $1,531 |
| Januvia | 23 | $35,566 | $1,546 |
| Novolog Flexpen | 37 | $25,997 | $703 |
| Ozempic | 15 | $22,731 | $1,515 |
| Semglee (Yfgn) | 37 | $12,663 | $342 |
| Lantus Solostar | 26 | $10,272 | $395 |
| Basaglar Kwikpen U-100 | 49 | $9,250 | $189 |
| Ultra-Fine Short Pen Needle | 29 | $3,338 | $115 |
| Metformin | 132 | $2,934 | $22 |
| Glipizide | 104 | $2,620 | $25 |
| Ultra-Fine Mini Pen Needle | 34 | $2,299 | $68 |
| Atorvastatin | 86 | $2,225 | $26 |
| Metformin Hcl Er | 32 | $1,447 | $45 |
| Ultra-Fine Nano Pen Needle | 12 | $1,308 | $109 |
| Fosinopril | 40 | $1,050 | $26 |
| Amlodipine Besylate | 59 | $687 | $12 |
| Simvastatin | 29 | $523 | $18 |
| Insulin | 12 | $517 | $43 |
| Atenolol | 12 | $315 | $26 |
| Losartan | 25 | $284 | $11 |
| Lisinopril | 13 | $171 | $13 |
| Hydrochlorothiazide | 23 | $54 | $2 |
2022: 30 drugs
| Trulicity | 94 | $177,991 | $1,894 |
| Jardiance | 102 | $137,584 | $1,349 |
| Januvia | 64 | $86,967 | $1,359 |
| Tradjenta | 30 | $43,199 | $1,440 |
| Lantus Solostar | 53 | $25,606 | $483 |
| Basaglar Kwikpen U-100 | 35 | $20,568 | $588 |
| Novolog Flexpen | 25 | $18,664 | $747 |
| Novolog | 12 | $9,667 | $806 |
| Lantus | 18 | $9,512 | $528 |
| Ozempic | 11 | $7,517 | $683 |
| Novolin 70-30 | 14 | $7,372 | $527 |
| Ultra-Fine Short Pen Needle | 43 | $3,445 | $80 |
| Metformin | 150 | $2,429 | $16 |
| Ultra-Fine Mini Pen Needle | 27 | $2,214 | $82 |
| Atorvastatin | 116 | $2,160 | $19 |
| Glipizide | 151 | $2,029 | $13 |
| Insulin | 26 | $1,754 | $67 |
| Fosinopril | 55 | $1,241 | $23 |
| Ultra-Fine Nano Pen Needle | 11 | $1,044 | $95 |
| Amlodipine Besylate | 81 | $819 | $10 |
| Insulin | 22 | $818 | $37 |
| Losartan | 32 | $642 | $20 |
| Atenolol | 27 | $625 | $23 |
| Insulin | 11 | $609 | $55 |
| Simvastatin | 55 | $566 | $10 |
| Metformin Hcl Er | 26 | $480 | $18 |
| Lisinopril | 25 | $316 | $13 |
| Benazepril | 20 | $254 | $13 |
| Metoprolol | 20 | $217 | $11 |
| Hydrochlorothiazide | 29 | $114 | $4 |
2021: 32 drugs
| Trulicity | 208 | $218,702 | $1,051 |
| Januvia | 123 | $164,557 | $1,338 |
| Jardiance | 99 | $122,325 | $1,236 |
| Lantus Solostar | 90 | $44,159 | $491 |
| Tradjenta | 28 | $38,527 | $1,376 |
| Novolog Flexpen | 29 | $34,500 | $1,190 |
| Basaglar Kwikpen U-100 | 53 | $31,816 | $600 |
| Lantus | 43 | $31,185 | $725 |
| Ozempic | 26 | $27,865 | $1,072 |
| Novolog | 28 | $16,481 | $589 |
| Novolin 70-30 | 14 | $7,674 | $548 |
| Ultra-Fine Mini Pen Needle | 65 | $3,918 | $60 |
| Novolin N | 17 | $3,114 | $183 |
| Glipizide | 211 | $2,899 | $14 |
| Ultra-Fine Short Pen Needle | 40 | $2,470 | $62 |
| Atorvastatin | 153 | $2,449 | $16 |
| Metformin | 226 | $2,446 | $11 |
| Insulin | 28 | $1,802 | $64 |
| Fosinopril | 61 | $1,346 | $22 |
| Insulin | 35 | $1,318 | $38 |
| Ultra-Fine Nano Pen Needle | 19 | $1,104 | $58 |
| Insulin | 15 | $1,013 | $68 |
| Amlodipine Besylate | 88 | $781 | $9 |
| Atenolol | 52 | $543 | $10 |
| Simvastatin | 76 | $531 | $7 |
| Losartan | 35 | $467 | $13 |
| Metformin Hcl Er | 28 | $393 | $14 |
| Lisinopril | 33 | $315 | $10 |
| Metoprolol | 27 | $288 | $11 |
| Benazepril | 25 | $224 | $9 |
| Pravastatin | 16 | $210 | $13 |
| Hydrochlorothiazide | 32 | $119 | $4 |
2020: 30 drugs
| Trulicity | 219 | $187,196 | $855 |
| Januvia | 102 | $127,160 | $1,247 |
| Jardiance | 43 | $41,914 | $975 |
| Tradjenta | 29 | $36,007 | $1,242 |
| Lantus Solostar | 91 | $32,391 | $356 |
| Basaglar Kwikpen U-100 | 67 | $28,648 | $428 |
| Novolog Flexpen | 22 | $24,973 | $1,135 |
| Lantus | 42 | $24,509 | $584 |
| Tresiba Flextouch U-200 | 11 | $20,693 | $1,881 |
| Ozempic | 22 | $20,007 | $909 |
| Novolog | 19 | $14,567 | $767 |
| Ultra-Fine Short Pen Needle | 60 | $3,012 | $50 |
| Ultra-Fine Mini Pen Needle | 43 | $2,725 | $63 |
| Glipizide | 221 | $2,227 | $10 |
| Atorvastatin | 157 | $2,154 | $14 |
| Metformin | 232 | $2,118 | $9 |
| Insulin | 24 | $1,360 | $57 |
| Insulin | 33 | $1,174 | $36 |
| Fosinopril | 41 | $852 | $21 |
| Amlodipine Besylate | 109 | $726 | $7 |
| Losartan | 36 | $663 | $18 |
| Levothyroxine | 15 | $429 | $29 |
| Simvastatin | 74 | $380 | $5 |
| Atenolol | 43 | $379 | $9 |
| Pravastatin | 14 | $278 | $20 |
| Metoprolol | 27 | $260 | $10 |
| Lisinopril | 36 | $239 | $7 |
| Metformin Hcl Er | 14 | $183 | $13 |
| Hydrochlorothiazide | 28 | $162 | $6 |
| Benazepril | 17 | $147 | $9 |
2019: 25 drugs
| Trulicity | 187 | $143,135 | $765 |
| Januvia | 55 | $69,379 | $1,261 |
| Novolog Flexpen | 29 | $31,271 | $1,078 |
| Lantus Solostar | 61 | $29,699 | $487 |
| Jardiance | 23 | $26,472 | $1,151 |
| Tresiba Flextouch U-200 | 14 | $25,307 | $1,808 |
| Tradjenta | 21 | $24,752 | $1,179 |
| Basaglar Kwikpen U-100 | 55 | $21,096 | $384 |
| Lantus | 17 | $13,193 | $776 |
| Ozempic | 12 | $10,963 | $914 |
| Ultra-Fine Short Pen Needle | 54 | $2,965 | $55 |
| Metformin | 122 | $1,458 | $12 |
| Atorvastatin | 81 | $1,177 | $15 |
| Ultra-Fine Mini Pen Needle | 21 | $1,132 | $54 |
| Glipizide | 126 | $1,012 | $8 |
| Insulin | 12 | $700 | $58 |
| Fosinopril | 18 | $443 | $25 |
| Amlodipine Besylate | 49 | $363 | $7 |
| Simvastatin | 48 | $297 | $6 |
| Losartan | 39 | $290 | $7 |
| Hydrochlorothiazide | 28 | $202 | $7 |
| Lisinopril | 27 | $169 | $6 |
| Benazepril | 14 | $168 | $12 |
| Atenolol | 18 | $124 | $7 |
| Metoprolol | 11 | $107 | $10 |
2018: 27 drugs
| Januvia | 47 | $56,885 | $1,210 |
| Lantus Solostar | 65 | $32,914 | $506 |
| Lantus | 52 | $31,672 | $609 |
| Trulicity | 36 | $28,167 | $782 |
| Novolog Flexpen | 18 | $23,839 | $1,324 |
| Novolog | 15 | $17,563 | $1,171 |
| Tradjenta | 14 | $15,997 | $1,143 |
| Basaglar Kwikpen U-100 | 29 | $12,249 | $422 |
| Acarbose | 27 | $1,677 | $62 |
| Ultra-Fine Short Pen Needle | 29 | $1,312 | $45 |
| Atorvastatin | 69 | $1,216 | $18 |
| Metformin | 101 | $1,181 | $12 |
| Glipizide | 112 | $1,119 | $10 |
| Insulin | 20 | $1,044 | $52 |
| Insulin | 23 | $961 | $42 |
| Ultra-Fine Mini Pen Needle | 12 | $556 | $46 |
| Fosinopril | 14 | $316 | $23 |
| Benazepril | 31 | $314 | $10 |
| Pravastatin | 11 | $301 | $27 |
| Gabapentin | 15 | $280 | $19 |
| Simvastatin | 46 | $263 | $6 |
| Amlodipine Besylate | 35 | $250 | $7 |
| Atenolol | 25 | $235 | $9 |
| Losartan | 20 | $195 | $10 |
| Hydrochlorothiazide | 31 | $188 | $6 |
| Metoprolol | 12 | $131 | $11 |
| Lisinopril | 14 | $116 | $8 |
2017: 39 drugs
| Novolin 70-30 | 144 | $32,140 | $223 |
| Novolin N | 110 | $23,050 | $210 |
| Januvia | 36 | $22,459 | $624 |
| Lantus | 35 | $21,036 | $601 |
| Novolog Flexpen | 14 | $12,509 | $893 |
| Novolog | 12 | $12,412 | $1,034 |
| Spiriva | 11 | $9,125 | $830 |
| Lantus Solostar | 26 | $6,822 | $262 |
| Novolin R | 35 | $6,207 | $177 |
| Dulera | 15 | $4,503 | $300 |
| Insulin | 126 | $3,348 | $27 |
| Qvar | 12 | $2,586 | $215 |
| Metformin Hcl Er | 37 | $1,936 | $52 |
| Warfarin | 104 | $1,627 | $16 |
| Acarbose | 21 | $1,383 | $66 |
| Metformin | 154 | $1,263 | $8 |
| Insulin | 43 | $1,162 | $27 |
| Glipizide | 110 | $969 | $9 |
| Atorvastatin | 68 | $928 | $14 |
| Metoprolol | 19 | $424 | $22 |
| Simvastatin | 61 | $410 | $7 |
| Insulin | 11 | $353 | $32 |
| Pravastatin | 25 | $345 | $14 |
| Levothyroxine | 15 | $319 | $21 |
| Hydrochlorothiazide | 49 | $312 | $6 |
| Lisinopril | 54 | $304 | $6 |
| Amlodipine Besylate | 58 | $292 | $5 |
| Fosinopril | 13 | $268 | $21 |
| Losartan | 41 | $266 | $6 |
| Tamsulosin | 12 | $239 | $20 |
| Hydralazine | 16 | $229 | $14 |
| Glimepiride | 18 | $219 | $12 |
| Furosemide | 39 | $201 | $5 |
| Allopurinol | 11 | $188 | $17 |
| Omeprazole | 17 | $154 | $9 |
| Atenolol | 20 | $136 | $7 |
| Benazepril | 15 | $117 | $8 |
| Carvedilol | 16 | $111 | $7 |
| Prednisone | 12 | $41 | $3 |
2016: 44 drugs
| Novolin 70-30 | 333 | $71,427 | $214 |
| Novolin N | 200 | $38,022 | $190 |
| Januvia | 29 | $11,242 | $388 |
| Metformin Hcl Er | 26 | $10,760 | $414 |
| Novolin R | 46 | $6,215 | $135 |
| Insulin | 173 | $4,130 | $24 |
| Warfarin | 204 | $3,851 | $19 |
| Proair Hfa | 40 | $2,456 | $61 |
| Metformin | 204 | $1,880 | $9 |
| Atorvastatin | 88 | $1,402 | $16 |
| Insulin | 55 | $1,338 | $24 |
| Glipizide | 123 | $1,005 | $8 |
| Simvastatin | 97 | $897 | $9 |
| Acarbose | 14 | $879 | $63 |
| Metoprolol | 29 | $754 | $26 |
| Potassium Chloride | 17 | $626 | $37 |
| Isosorbide Dinitrate | 11 | $615 | $56 |
| Oxybutynin Chloride Er | 17 | $613 | $36 |
| Omeprazole | 46 | $599 | $13 |
| Lisinopril | 81 | $598 | $7 |
| Gabapentin | 20 | $552 | $28 |
| Pravastatin | 17 | $527 | $31 |
| Glimepiride | 24 | $516 | $22 |
| Losartan | 58 | $491 | $8 |
| Fosinopril | 22 | $432 | $20 |
| Valsartan | 11 | $420 | $38 |
| Glipizide Er | 18 | $405 | $22 |
| Furosemide | 53 | $362 | $7 |
| Levothyroxine | 23 | $354 | $15 |
| Hydrochlorothiazide | 46 | $343 | $7 |
| Metoprolol | 43 | $326 | $8 |
| Tamsulosin | 16 | $304 | $19 |
| Allopurinol | 14 | $270 | $19 |
| Amlodipine Besylate | 59 | $259 | $4 |
| Losartan-Hydrochlorothiazide | 19 | $256 | $13 |
| Azithromycin | 28 | $189 | $7 |
| Carvedilol | 20 | $174 | $9 |
| Prednisone | 26 | $150 | $6 |
| Amoxicillin-Clavulanate Potass | 12 | $149 | $12 |
| Atenolol | 26 | $128 | $5 |
| Hydralazine | 13 | $120 | $9 |
| Lisinopril-Hydrochlorothiazide | 14 | $114 | $8 |
| Benazepril | 12 | $111 | $9 |
| Clonidine | 14 | $99 | $7 |
2015: 25 drugs
| Novolin 70-30 | 61 | $7,457 | $122 |
| Januvia | 11 | $3,817 | $347 |
| Proair Hfa | 15 | $1,136 | $76 |
| Novolin N | 13 | $1,029 | $79 |
| Hydrocodone-Acetaminophen | 28 | $822 | $29 |
| Warfarin | 32 | $630 | $20 |
| Metformin | 61 | $514 | $8 |
| Insulin | 21 | $439 | $21 |
| Omeprazole | 30 | $371 | $12 |
| Simvastatin | 44 | $354 | $8 |
| Nifedical Xl | 18 | $353 | $20 |
| Gabapentin | 19 | $341 | $18 |
| Potassium Chloride | 14 | $335 | $24 |
| Levothyroxine | 20 | $322 | $16 |
| Tamsulosin | 14 | $295 | $21 |
| Atorvastatin | 15 | $228 | $15 |
| Lisinopril-Hydrochlorothiazide | 22 | $149 | $7 |
| Allopurinol | 14 | $143 | $10 |
| Glipizide | 17 | $126 | $7 |
| Azithromycin | 15 | $113 | $8 |
| Lisinopril | 15 | $107 | $7 |
| Amlodipine Besylate | 21 | $106 | $5 |
| Metoprolol | 20 | $97 | $5 |
| Tramadol | 15 | $94 | $6 |
| Lorazepam | 11 | $79 | $7 |
Money from drug and device companies
$149 in 2025
| 2025 | 1 | 1 | None | $149 |
| 2023 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Insulet | Omnipod | $149 | 1 payment
|
See the published payment
| Insulet | Meals · 2025-10-30 | Omnipod | $149 |
See earlier years (2023)
2023: $16
| Boston Scientific | Superion Indirect Decompression System | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1942690946
- Licence
- CA 95001933
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 255 N White Rd, Ste 200, San Jose, CA, 95127
- NPI first listed
- 2015-01-28
- NPI last updated
- 2017-02-02
This is when the NPI record was last certified, not a medical board exam.